This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
—The majority of the patients in our study were white (93% in the placebo group, 86% in the salmeterol group, and 91% in the albuterol group); 2%, 4%, and 5%, respectively, were African American, and 4%, 8%, and 4%, respectively, were Hispanic. Because of the small number of nonwhites in the study, no statistical analyses were performed to compare differences in efficacy among ethnic groups.
D'Alonzo GE. Salmeterol Xinafoate vs Albuterol in Asthma: Was Race a Factor?-Reply. JAMA. 1994;272(20):1576. doi:10.1001/jama.1994.03520200032024